Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF Jan. 18, 2013 | Archived Issues

FDA lowers recommended dose of zolpidem products

Pharmacy focus

The U.S. Food and Drug Administration is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that the bedtime dose be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving.

» Read more


Meetings and events


Grand rounds

Click here to view upcoming grand rounds.


Upcoming CME conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

Medical Staff CME Newsletter - January 2013 (PDF)

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Changes coming for Infectious Diseases

As the healthcare environment continues to present challenges to integrated health systems, Cedars-Sinai faces difficult decisions regarding organizational structure and staffing. One of these decisions involves the Division of Infectious Diseases in the Department of Medicine. Starting in July, the outpatient and inpatient Infectious Diseases services of the Department of Medicine will be staffed primarily by private attending medical staff members of the Division of Infectious Diseases, instead of full-time faculty infectious disease physicians. The division's clinical and educational programs – including those serving people with HIV and AIDS, as well as the resident and fellowship training programs – will continue.

"The full-time faculty and staff in Infectious Diseases have done an outstanding job over the years, so this is a hard change for everyone," said Zab Mosenifar, MD, executive vice-chair of the Department of Medicine. "I would particularly like to acknowledge the leadership of Dr. W. David Hardy, and thank him and Drs. Paula Gaut and Yoko Miyasaki for their many contributions to Cedars-Sinai. We wish them all the best as they pursue the next chapters in their exemplary professional careers."

Dr. Miyasaki will continue her research in the Department of Biomedical Sciences. The two other Infectious Diseases faculty, Rekha Murthy, MD, and Jonathan Grein, MD, and their staff will remain in their current positions in Hospital Epidemiology as well as members of the Division.

Cedars-Sinai is fortunate to have a number of outstanding infectious disease specialists on its medical staff, so this transition is expected to go smoothly.

Phillip Zakowski, MD, a longtime private attending physician in Infectious Diseases who has won numerous Golden Apple Awards for teaching, has agreed to serve as the coordinator for the Infectious Diseases Fellowship Training Program. Sam Alkasspooles, MD, will continue to serve as clinical chief of Infectious Diseases. Zab Mosenifar, MD, will be the Department of Medicine's liaison to ensure that all Infectious Diseases programs transition smoothly and effectively.

Questions about this transition can be addressed to Dr. Mosenifar at mosenifarz@cshs.org.